CDXS
Codexis, Inc.
1 day chart
About CDXS
Codexis, Inc. is an enzyme engineering company. The Company is engaged in discovering, developing and sells enzymes and other proteins. It operates through two segments: Performance Enzymes and Novel Biotherapeutics. The Company’s CodeEvolver technology platform accelerates biologic discovery through the transformation of a starting enzyme into a biocatalyst or therapeutic candidate. The Company has commercialized its CodeEvolver protein engineering technology platform and products in the pharmaceutical’s markets. Its products include biocatalysts, chemical intermediates and Codex biocatalyst panels and kits. It also commercialized three additional enzymes, such as Codex HiFi DNA Polymerase for use in next generation sequencing, Codex HiTemp Reverse Transcriptase for use in molecular diagnostic applications, and Codex HiCap RNA Polymerase for use in RNA synthesis applications. The Company is developing its lead program, CDX-6114 for the treatment of hyperphenylalaninemia (HPA).
Buy US stocks in Australia with $0 brokerage and trade CDXS today!
$397.55M
-
0.00%
0
$6.16
$5.73
$0.00
$42.01
$6.04
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.